NO20044688L - Visse 1-(D-cyklopropylglysinyl)-4-(piperidin-4-yl)piperazinforbindelser som inhibitorer for serin proteasefaktor Xa - Google Patents

Visse 1-(D-cyklopropylglysinyl)-4-(piperidin-4-yl)piperazinforbindelser som inhibitorer for serin proteasefaktor Xa

Info

Publication number
NO20044688L
NO20044688L NO20044688A NO20044688A NO20044688L NO 20044688 L NO20044688 L NO 20044688L NO 20044688 A NO20044688 A NO 20044688A NO 20044688 A NO20044688 A NO 20044688A NO 20044688 L NO20044688 L NO 20044688L
Authority
NO
Norway
Prior art keywords
inhibitors
cyclopropylglyinyl
piperidin
certain
serine protease
Prior art date
Application number
NO20044688A
Other languages
English (en)
Inventor
Gary Lowell Engel
Michael Robert Wiley
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO20044688L publication Critical patent/NO20044688L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56—Nitrogen atoms
    • C07D211/58—Nitrogen atoms attached in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/44—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C235/52—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Legemiddel
NO20044688A 2002-04-01 2004-10-29 Visse 1-(D-cyklopropylglysinyl)-4-(piperidin-4-yl)piperazinforbindelser som inhibitorer for serin proteasefaktor Xa NO20044688L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36852302P 2002-04-01 2002-04-01
PCT/US2003/007794 WO2003084929A1 (en) 2002-04-01 2003-03-24 Certain 1-(d-cyclopropylglycinyl)-4-(piperidin-4-yl)piperazine compounds as inhibitors of the serine protease factor xa

Publications (1)

Publication Number Publication Date
NO20044688L true NO20044688L (no) 2004-10-29

Family

ID=28791889

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20044688A NO20044688L (no) 2002-04-01 2004-10-29 Visse 1-(D-cyklopropylglysinyl)-4-(piperidin-4-yl)piperazinforbindelser som inhibitorer for serin proteasefaktor Xa

Country Status (25)

Country Link
US (1) US7166606B2 (no)
EP (1) EP1492767B1 (no)
JP (1) JP2005531529A (no)
KR (1) KR20040094892A (no)
CN (1) CN1288135C (no)
AT (1) ATE303990T1 (no)
AU (1) AU2003218147A1 (no)
BR (1) BR0308870A (no)
CA (1) CA2478340A1 (no)
CR (1) CR7497A (no)
DE (1) DE60301569T2 (no)
DK (1) DK1492767T3 (no)
EA (1) EA007300B1 (no)
EC (1) ECSP045329A (no)
ES (1) ES2248737T3 (no)
HK (1) HK1070363A1 (no)
HR (1) HRP20040900B1 (no)
IL (1) IL164018A0 (no)
MX (1) MXPA04009640A (no)
NO (1) NO20044688L (no)
NZ (1) NZ535402A (no)
PL (1) PL373066A1 (no)
UA (1) UA76849C2 (no)
WO (1) WO2003084929A1 (no)
ZA (1) ZA200407418B (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6834308B1 (en) 2000-02-17 2004-12-21 Audible Magic Corporation Method and apparatus for identifying media content presented on a media playing device
US7363278B2 (en) 2001-04-05 2008-04-22 Audible Magic Corporation Copyright detection and protection system and method
US8972481B2 (en) 2001-07-20 2015-03-03 Audible Magic, Inc. Playlist generation method and apparatus
DE102014108210A1 (de) 2014-06-11 2015-12-17 Dietrich Gulba Rodentizid
US11014920B2 (en) 2016-11-18 2021-05-25 Merck Sharp & Dohme Corp. Factor XIIa inhibitors
EP4070658A1 (de) 2021-04-06 2022-10-12 BIORoxx GmbH Verwendung von blutgerinnungshemmenden verbindungen als rodentizide

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1009758B1 (en) 1997-08-29 2005-06-01 Tularik Limited Meta-benzamidine derivatives as serine protease inhibitors
AU5413600A (en) 1999-06-14 2001-01-02 Eli Lilly And Company Compounds
JP2003502314A (ja) 1999-06-14 2003-01-21 イーライ・リリー・アンド・カンパニー 化合物
GB0030303D0 (en) 2000-12-13 2001-01-24 Lilly Co Eli Compounds
GB0030306D0 (en) 2000-12-13 2001-01-24 Lilly Co Eli Compounds
GB0030305D0 (en) 2000-12-13 2001-01-24 Lilly Co Eli Compounds
GB0030304D0 (en) * 2000-12-13 2001-01-24 Lilly Co Eli Compounds
TWI257389B (en) 2001-06-12 2006-07-01 Lilly Co Eli Pharmaceutical compound
ES2298386T3 (es) * 2001-07-26 2008-05-16 Eli Lilly And Company 1-glicinil-4-(1-metilpiperidin-4-il)piperazinas y -piperidinas como antagonistas del factor xa.

Also Published As

Publication number Publication date
CN1288135C (zh) 2006-12-06
HRP20040900B1 (en) 2006-02-28
DK1492767T3 (da) 2005-11-28
HK1070363A1 (en) 2005-06-17
KR20040094892A (ko) 2004-11-10
EA007300B1 (ru) 2006-08-25
WO2003084929A8 (en) 2004-05-21
ZA200407418B (en) 2005-09-15
DE60301569D1 (de) 2005-10-13
US20050096328A1 (en) 2005-05-05
ECSP045329A (es) 2004-11-26
DE60301569T2 (de) 2006-06-14
JP2005531529A (ja) 2005-10-20
CN1642914A (zh) 2005-07-20
IL164018A0 (en) 2005-12-18
PL373066A1 (en) 2005-08-08
BR0308870A (pt) 2005-01-04
EP1492767A1 (en) 2005-01-05
ATE303990T1 (de) 2005-09-15
UA76849C2 (uk) 2006-09-15
HRP20040900A2 (en) 2004-12-31
EP1492767B1 (en) 2005-09-07
WO2003084929A1 (en) 2003-10-16
AU2003218147A1 (en) 2003-10-20
ES2248737T3 (es) 2006-03-16
US7166606B2 (en) 2007-01-23
EA200401290A1 (ru) 2005-02-24
CA2478340A1 (en) 2003-10-16
MXPA04009640A (es) 2005-01-11
NZ535402A (en) 2006-02-24
CR7497A (es) 2005-01-17

Similar Documents

Publication Publication Date Title
HK1091121A1 (en) Substituted 2-aminotetralins for the treatment of depressions
NO20062021L (no) Omleirede pentanoler, fremgangsmpte for fremstilling av dette, og deres anvendelse som antiflogistika
NO20070201L (no) Seksleddede heterocykler anvendelige som serinproteaseinhibitorer
DK1836201T4 (da) Pyrrolidininhibitorer af IAP.
DE602006011752D1 (de) Als antikoagulationsmittel geeignete phenylglycinamid- und pyridylglycinamidderivate
WO2006047528A3 (en) Pyrazolobenzamides and derivatives as factor xa inhibitors
IS6902A (is) N-setin heterósýklísk NMDA/NR2B mótlyf sem ekki eru arýl
GEP20074098B (en) Lactam-containing compounds and derivatives thereof as factor xa inhibitors
RS20050046A (en) 3-z-/1-(4-(n-((4-methyl-piperazin-1-yl)- methylcarbonyl)-n- methyl-amino)- anilino)-1-phenyl-methylene/-6- methoxycarbonyl -2-indolinone- monoethanesulphonate and the use thereof as a pharmaceutical composition
NO20050199L (no) Azadisyklo-oktan og nonanderivater med DDP-IV-inhiberende aktivitet
MX2007000505A (es) Derivados de oxindol sustituidos y medicamentos que contienen los mismos.
NO20082629L (no) Macrocyklisk factor VIIa-inhibitorer anvendbare som antikoagulanter
NO20063944L (no) Piperidinylkarbonyl-pyrrolidiner og deres anvendelse som melanokortinagonister
GB0426313D0 (en) Therapeutic agents
WO2004031145A3 (en) Lactam-containing diaminoalkyl, beta-aminoacids, alpha-aminoacids and derivatives thereof as factor xa inhibitors
HK1070363A1 (en) Certain 1-(d-cyclopropylglycinyl)-4-(piperidin-4-yl)piperazine compounds as inhibitors of the serineprotease factor xa
DE602004018811D1 (de) Pyrrolidinylharnstoffderivate als angiogeneseinhibitoren
AR039937A1 (es) Derivados de azetidina como inhibidores de tripsina proteasas
NO20030297L (no) Aryl sulfonamider som serotoninantagonist for behandling av fedme
MY137876A (en) Pharmaceutical compound
DK1637141T3 (da) Stabiliseret proteasesammensætning omfattende en serinprotease, morpholinderivater og reversible inhibitorer af serinproteasen
EA200601086A1 (ru) Новый способ синтеза периндоприла и его фармацевтически приемлемых солей
EA200700186A1 (ru) Фармацевтическое соединение
DE60224805D1 (de) 1-glycinyl-4-(1-methylpiperidin-4-yl)piperazine un
SI1492767T1 (sl) Dolocene 1-(d-ciklopropilglicinil)-4-(piperidin-4-il)piperazinske spojine kot inhibitorji faktorja xa serinske proteaze

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application